Abstract
Twenty-five patients with severe and unusually resistant bacterial infections were treated with nitrofurantoin given intravenously.
Twelve patients were classified as cured and seven as improved. In two cases there was no observable benefit. The other four patients, all moribund at the beginning of nitrofurantoin therapy, died. No significant toxic reaction to the drug was noted except for a tendency to metabolic acidosis in five patients in a state of shock after treatment with nitrofurantoin (Furadantin® intravenous solution). In no case was there evidence of impaired hematopoiesis.
From this preliminary report it appeared that nitrofurantoin for intravenous use is justified in the treatment of gravely ill patients with surgical infections resistant to other antimicrobial drugs.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- TRAFTON H. M., BEUTNER E. H., PETRONIO J. J., LIND H. E., CORREIA-BRANCO M. Furadantin in urinary-tract infections; clinical and laboratory studies. N Engl J Med. 1955 Mar 10;252(10):383–387. doi: 10.1056/NEJM195503102521003. [DOI] [PubMed] [Google Scholar]